<?xml version="1.0" encoding="UTF-8"?>
<fig fig-type="Figure" xml:lang="en" id="cas13719-fig-0001" orientation="portrait" position="float">
 <label>Figure 1</label>
 <caption>
  <p>Study design. Ara‐C, cytarabine; 
   <styled-content style="fixed-case">CPA</styled-content>, cyclophosphamide; 
   <styled-content style="fixed-case">CR</styled-content>, complete response; Dexa, dexamethasone; 
   <styled-content style="fixed-case">DXR</styled-content>, doxorubicin; 
   <styled-content style="fixed-case">ETP</styled-content>, etoposide; L‐
   <styled-content style="fixed-case">PAM</styled-content>, melphalan; 
   <styled-content style="fixed-case">MCL</styled-content>, mantle cell lymphoma; 
   <styled-content style="fixed-case">PBSCT</styled-content>, peripheral blood stem cell transplantation; 
   <styled-content style="fixed-case">PD</styled-content>, progression of disease; 
   <styled-content style="fixed-case">PR</styled-content>, partial response; 
   <styled-content style="fixed-case">PS</styled-content>, performance status; 
   <styled-content style="fixed-case">PSL</styled-content>, prednisolone; 
   <styled-content style="fixed-case">SD</styled-content>, stable disease; 
   <styled-content style="fixed-case">VCR</styled-content>, vincristine
  </p>
 </caption>
 <graphic id="nlm-graphic-3" xlink:href="CAS-109-2830-g001" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
